Cost-effectiveness of the Three I's for HIV/TB and ART to prevent TB among people living with HIV. [electronic resource]
- The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease Oct 2014
- 1159-65 p. digital
Publication Type: Journal Article
1815-7920
10.5588/ijtld.13.0571 doi
Algorithms Antitubercular Agents--therapeutic use CD4 Lymphocyte Count Cost-Benefit Analysis Drug Resistance, Bacterial HIV Infections--drug therapy Humans Isoniazid--therapeutic use Models, Economic Mycobacterium tuberculosis--drug effects Radiography Rifampin--therapeutic use Sensitivity and Specificity Tuberculosis--diagnosis